SYNTHESIS OF THE SPIROKETAL SUBUNIT OF REVEROMYCIN A
瑞维霉素 A 螺酮亚基的合成
基本信息
- 批准号:6028231
- 负责人:
- 金额:$ 10.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Applicant's Abstract) The long-term goal of this research is to
develop a stereocontrolled synthetic route to the antitumor agent reveromycin
A. Toward this goal, as detailed in this application, we propose to synthesize
the spiroketal subunit bearing the C10-C24 framework of this natural product.
Isolated from a soil actinomycete, reveromycin A is an inhibitor of mitogenic
activity induced by epidermal growth factor, and is also active against human
tumor cell lines KB and K562. This research is important for two main reasons.
First, through synthesis, we eventually hope to confirm the absolute structure
assigned to the natural product by Ubukata and co-workers using NOE
experiments. Second, a large-scale, practical route to this molecule would
provide access to analogues for structure-activity studies.
A study of intramolecular reactions on the 6,6-spiroketal framework is
proposed. It is hoped that the conformational rigidity of the spirocyclic ring
systems will make the intended ring closures entropically favored. Using this
strategy we wish to establish the stereorelationship between the C19- and C11-
stereocenters of the natural product molecule. A hypothesis to be addressed is
whether an inntramolecular axial bond can be made to C2 on a spiroketal ring
(C19 in reveromycin A) from an equatorial C8-substituent (C11 in reveromycin
A).
Cyclizations by both one- and two-electron processes will be studied. In one
project, a C2-centered radical will be generated and added to a beta-stannyl
ester in endocyclic fashion on the C8-side chain. The intended outcome is an
intramolecular radical substitution with loss of the beta-stannyl group. The
interconnective aliphatic chain will be chosen so that lactone cleavage in the
product would yield C2- and C8-groups which could be converted to the C19- and
C11-side chains, respectively, of reveromycin A.
In another study, attempts will be made to generate and trap a C2-oxonium ion
intramolecularly by allyl- and vinylsilanes on the C8-side chain. This strategy
will be investigated as an alternative route to the reveromycin A spiroketal.
(申请人摘要)本研究的长期目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEITH Thomas MEAD其他文献
KEITH Thomas MEAD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEITH Thomas MEAD', 18)}}的其他基金
Efficient Assemblage of Complex Biologically-Active Targets Using Donor-Acceptor
使用供体-受体有效组装复杂的生物活性靶标
- 批准号:
8364688 - 财政年份:2012
- 资助金额:
$ 10.43万 - 项目类别:
A Synthetic Approach to Calyxins and Epicalyxins I and J
萼蛋白和表萼蛋白 I 和 J 的合成方法
- 批准号:
7126978 - 财政年份:2006
- 资助金额:
$ 10.43万 - 项目类别:
Synthetic Approaches to Blepharocalyxins D and E
眼睑萼蛋白 D 和 E 的合成方法
- 批准号:
6666077 - 财政年份:2003
- 资助金额:
$ 10.43万 - 项目类别:
SYNTHESIS OF THE SPIROKETAL SUBUNIT OF REVEROMYCIN A
瑞维霉素 A 螺酮亚基的合成
- 批准号:
6473754 - 财政年份:2000
- 资助金额:
$ 10.43万 - 项目类别:
APPROACH TO THE SPIROKETAL RINGS OF THE ALTOHYRTINS
阿尔托蛋白螺酮环的研究
- 批准号:
2114702 - 财政年份:1996
- 资助金额:
$ 10.43万 - 项目类别:
STEREOCONTROLLED APPROACH TO PAMAMYCIN-607
PAMAMYCIN-607 的立体控制方法
- 批准号:
2183676 - 财政年份:1991
- 资助金额:
$ 10.43万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 10.43万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 10.43万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 10.43万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 10.43万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 10.43万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 10.43万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 10.43万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 10.43万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 10.43万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 10.43万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)